All Articles
Every article, newest first.
Telmisartan: The Cardio-Metabolic Protection Case for High-Androgen Use and TRT
Telmisartan is a genuinely unique blood pressure medication with real evidence for reversing heart enlargement and improving insulin sensitivity — the mechanistic case for using it alongside androgen therapy is strong, even where the direct combined research doesn't yet exist.
TRT for Men: The Real Benefits, the Myths, and What True Hormone Optimization Actually Looks Like
Testosterone replacement can be genuinely life-changing — but the honest picture includes real unresolved questions too. A full look at the evidence for energy, libido, mood, metabolic health, and muscle, alongside the myths, the negatives, and the full hormone picture around it.
The FDA's Peptide Compounding Fight: What the July 2026 PCAC Meeting Means for Gray Market Access and Pricing
BPC-157, KPV, TB-500, and MOTS-c go in front of the FDA's compounding advisory committee this month. Here's what's actually being decided, why it won't immediately change the gray market, and what's scheduled next.
Parkinson's Disease: What It Is, What's FDA-Approved, and What GLP-1s, TRT, and Exercise Actually Do
GLP-1 drugs looked genuinely promising for Parkinson's in early trials — then a 667-patient meta-analysis said otherwise. Here's what the real research shows across medications, peptides, hormones, and exercise.
Retatrutide: The Next GLP-1? What We Know So Far
Retatrutide has moved from Phase 2 buzz to real Phase 3 data in the last few months. Here's what the actual trial results show, and how they stack up against tirzepatide and semaglutide.
Trenbolone: From Cattle Pellets to the Dorian Yates Era, and Why It's the Most Dangerous Compound in This Series
Trenbolone never had a legitimate human medical history the way Primobolan, Masteron, or Equipoise did — it went straight from cattle feedlots to the most extreme corner of bodybuilding, and the side effect profile reflects that.
Primobolan vs. Masteron: Shared Origins, Different Look
Both trace back to 1960s breast cancer research and both are DHT derivatives that resist conversion to estrogen — but the androgenic difference between them produces two genuinely different physique outcomes.
Melanotan I vs. Melanotan II: Same Origins, Very Different Safety Profiles
Both trace back to the same 1980s research program, but one became an FDA-approved orphan drug and the other stayed an unregulated tanning agent with a genuinely concerning real-world adverse event record. Here's how they actually differ.
Human Growth Hormone: From Pediatric Deficiency to Aging Adults — What the Research Actually Supports
HGH has one of the widest ranges of legitimate medical use of any hormone therapy — and one of the widest gaps between its approved uses and its anti-aging reputation. Here's what the research shows across children, AIDS patients, aging adults, and women specifically.
Rapamycin for Longevity: Promising Data, Real Caveats
Rapamycin is the most-replicated life-extension compound in animal research ever studied. The human data is finally catching up — and here's an honest look at whether any peptide comes close to doing what it does.
RUO vs. Clinical Use: Understanding the Peptide Research Landscape
Research-use-only compounds occupy a specific, legal, and often misunderstood space in the peptide world. Here's what the label actually means — and what it doesn't.
NAD+ and Aging: What the Studies Actually Show
NAD+ precursors reliably raise blood NAD+ levels in human trials — but "reliably raises a number" and "reliably improves aging" are different claims. Here's what the human data actually shows, and the other compounds researchers are studying alongside it.
What Is BPC-157? A Look at the Current Research
BPC-157 has over a hundred animal studies behind it and a passionate following online. Here's an honest look at what the animal data shows, how thin the human evidence actually is, and where the regulatory story stands right now.
Fertility on TRT: What the Research Actually Shows About hCG, hMG, and FSH Combinations
hCG alone, hCG plus hMG, or hCG plus FSH — the actual comparative trials show real differences in outcomes, not just theoretical ones. Here's what the research measured.
The Women's Health Initiative Got It Wrong — and Women Paid for It for Two Decades
In November 2025, the FDA finally removed the boxed warnings on hormone therapy it added after the 2002 WHI study. Here's what the WHI actually got wrong, and why it took 23 years to fix it.
Deca vs. NPP: Same Hormone, Different Ester, and a Neurological Side Effect Worth Understanding
Deca Durabolin built its reputation across decades of old-school bodybuilding and real clinical trials in wasting patients — but its most infamous side effect has a real, documented hormonal mechanism behind it.
Equipoise (Boldenone): From Human Drug to Racehorse Standard, and Its Hematocrit Problem
Equipoise started as a human drug in the 1960s, failed to find a place in medicine, and found its real home in veterinary racehorse care instead — with a hematocrit risk that follows the same mechanism covered elsewhere on this site.
Still Tired on TRT? Here's What to Look for in Your Bloodwork Before Blaming the Testosterone
Testosterone in range and still exhausted is one of the most common TRT complaints — and usually the answer isn't a dose change, it's somewhere else in the bloodwork nobody looked at yet.
PSA Explained: When to Actually Worry, How to Keep Your Prostate Healthy, and What TRT Really Does to It
A single PSA number gets treated like a verdict, but the research shows velocity and ratios matter more than any fixed cutoff — and TRT's effect on PSA is more predictable, and less alarming, than most men assume.
TRT and the Myths That Took Decades to Correct: Cardiovascular Risk, Prostate Cancer, and What the Data Actually Shows
For years, doctors were taught testosterone therapy causes heart attacks and prostate cancer. The actual data increasingly shows the opposite: low testosterone is the risk factor, and correcting it may be protective.
Bacteriostatic Water vs. Bacteriostatic Saline: Which Is Actually Better for Reconstitution?
Both diluents share the same preservative doing the real work — but that preservative has a documented interaction with protein structure worth knowing about, and it changes how you should think about storage.
CICO: What "Calories In, Calories Out" Actually Means, and Where It Gets Oversimplified
Energy balance is real physics — but the "calories in, calories out" slogan hides real biological complexity underneath it, including why the body pushes back against weight loss and why not every calorie source behaves identically.
SubQ vs. IM Testosterone Injections: What the Actual Trial Data Shows
Two real clinical trials have directly tested subcutaneous testosterone against the intramuscular standard — on blood levels, safety, and something most people actually care about more: how much it hurts.
How Many Sets, How Many Reps: What the Research Says About Building vs. Maintaining Muscle
The volume and rep-range research has gotten specific enough to answer two very different questions well: how much do you need to actually build muscle, and how little can you get away with just to keep what you've built?
Sauna Use: Dry vs. Wet, and What Temperature and Time Actually Show Benefit
The strongest sauna research comes almost entirely from Finnish dry sauna, at specific temperatures and durations most people aren't actually using. Here's what the real dose-response data shows.
Women's Hormone Replacement Therapy: Estrogen, Progesterone, and Testosterone — Delivery Methods, Who Benefits, and When
Women's HRT isn't one therapy — it's three hormones with three different jobs, three different delivery-method risk profiles, and a real age window where the benefit-to-risk ratio is best. Here's the complete picture.
Injections, Gels, Pellets, and Pills: Why Injectable Testosterone Remains the Gold Standard
Every TRT delivery method gets testosterone into your bloodstream — but they don't get there the same way, and that difference in route explains most of the real safety and reliability gaps between them.
Tirzepatide vs. Semaglutide: What the Head-to-Head Trials Show
For years, tirzepatide vs. semaglutide was argued from separate trials in different populations. SURMOUNT-5 finally put them head-to-head in the same study. Here's what it actually found.
High Hematocrit and Hemoglobin: What's Actually Driving It, and What the Research Says About Fixing It
Elevated hematocrit is the most common lab flag on TRT — but hydration status, sleep apnea, and even the "fix" of donating blood all complicate the picture more than a single number suggests.
High Estrogen in Men: Why the Number Alone Rarely Tells You Anything
A single estradiol number gets treated like a verdict — but research shows two men with wildly different levels can have identical symptoms, or none at all. Here's what actually matters, and what the evidence says about fixing real problems when they show up.
Time Under Tension, Training Frequency, and Proximity to Failure: What the Meta-Analyses Actually Show
Slow reps, training a muscle more often, and grinding out that last brutal rep are all popular advice — but the actual meta-analyses on each one tell a more forgiving story than gym culture usually lets on.
Recovery for Weekend Golfers: Mobility Work That Actually Moves the Needle
Thoracic rotation and hip mobility determine both your swing and your Monday morning. Here's the mobility work that actually matters, plus what the research says about the gym exercises that genuinely add clubhead speed.
Zone 2 Training Explained
Zone 2 gets credited with burning fat better than any other intensity — and for good physiological reason. But "burns more fat during the workout" and "makes you lose more weight" are different claims, and the research draws a clear line between them.
VO2 Max as a Longevity Marker: Why It Matters More Than You Think
If you could only track one number for how long you're likely to live, the research says it shouldn't be cholesterol or blood pressure. It should be VO2 max — and the data behind that claim is stronger than most people realize.
Natural Ways to Support Testosterone: Sleep, Lifting, and Diet
Sleep, resistance training, and body composition all move testosterone more than most people expect — and none of that stops mattering once you start TRT. Here's the research, and why the fundamentals don't become optional just because you're on therapy.
Low T Symptoms: What the Research Says About Diagnosis
The 300 ng/dL cutoff for "normal" testosterone gets treated like a hard biological line. It isn't — and relying on total testosterone alone misses a real category of men. Here's what the guidelines actually say, and where they fall short.
hCG on TRT, and the Other Hormones Worth Checking for Real Optimization
TRT restores one hormone. The men who actually feel their best on it are usually the ones whose thyroid, DHEA-S, and broader hormonal picture got checked too — not just testosterone in isolation.
Semax vs. Dihexa: Similar Pitch, Very Different Evidence Base
Both get marketed as powerful nootropic peptides derived from natural hormone systems. One has real human clinical trial data behind it. The other's foundational research paper was retracted for fabricated data. Here's the actual comparison.
Hydration Done Right: What to Look for in an Electrolyte Powder, and Why Plain Water Isn't Always Enough
Plain water has a real, well-documented failure mode during heavy sweating or endurance exercise. Here's what actually happens, what to look for in an electrolyte powder, and a practical rule of thumb for daily water intake.
KPV for Inflammation and Gut Health: Why It May Be a More Targeted Research Tool Than BPC-157
KPV and BPC-157 both show up in gut and inflammation research, but they work through genuinely different mechanisms — and KPV's lack of angiogenic activity may make it the more precise tool for inflammation-specific research questions.
GHK-Cu: How This Copper Peptide Works, and the Surprising Range of Things It Does
GHK-Cu started as a curiosity found in human blood plasma and turned into one of the most broadly-studied peptides in skin, wound, and tissue research. Here's the mechanism, and the real range of documented effects.
KLOW: What's Actually in the Blend, and What the Research on Each Component Shows
KLOW combines four peptides into one vial for a reason — but the research behind each component is stronger than the research behind combining them. Here's what's actually known.
Oral Anabolic Steroids Compared: Turinabol, Anavar, Dianabol, Anadrol, Halotestin, Proviron, and Superdrol
Seven oral compounds, seven very different origin stories and risk-benefit profiles — from a Cold War doping program to a genuinely still-prescribed pediatric burn treatment to a supplement-era liver toxin.
TRT and Fertility: What Men Should Know Before Starting
TRT suppresses natural sperm production in most men — but it doesn't have to end fertility. Here's what the research shows about hCG, FSH, and other options used to preserve or restore it.